Bionano Genomics (BNGO) Income from Continuing Operations (2017 - 2026)
Bionano Genomics recorded quarterly Income from Continuing Operations of 8303000.0 in Q1 2026, down 4.66% quarter-over-quarter from 7933000.0 in Q4 2025, and down 167.67% year-over-year from 12270560.27 in Q1 2025.
Bionano Genomics' Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 8303000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 167.67% year-over-year to 8303000.0; the TTM figure through Mar 2026 stood at 31596000.0 (up 62.45% YoY), while the FY2025 annual figure was 26395000.0, up 76.53% from the prior year.
- Income from Continuing Operations came in at 8303000.0 for Q1 2026 at Bionano Genomics, down from 7933000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3102000.0 in Q1 2025 to a low of 112566000.0 in Q3 2023.
- A 5-year average of 30131882.35 and a median of 31422000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 253.88% in 2023 and soared 90.13% in 2025, its largest moves.
- Bionano Genomics' Income from Continuing Operations stood at 38677000.0 in 2022, then decreased by 13.48% to 43891000.0 in 2023, then soared by 53.15% to 20563000.0 in 2024, then surged by 61.42% to 7933000.0 in 2025, then dropped by 4.66% to 8303000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 8303000.0, 7933000.0, and 8503000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -17.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn | -8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.30 Mn |
| Dec 31, 2025 | -7.93 Mn |
| Sep 30, 2025 | -8.50 Mn |
| Jun 30, 2025 | -6.86 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -20.56 Mn |
| Sep 30, 2024 | -44.25 Mn |
| Jun 30, 2024 | -16.22 Mn |
| Mar 31, 2024 | -31.42 Mn |
| Dec 31, 2023 | -43.89 Mn |
| Sep 30, 2023 | -112.57 Mn |
| Jun 30, 2023 | -38.91 Mn |
| Mar 31, 2023 | -37.12 Mn |
| Dec 31, 2022 | -38.68 Mn |
| Sep 30, 2022 | -31.81 Mn |
| Jun 30, 2022 | -32.16 Mn |
| Mar 31, 2022 | -29.95 Mn |
| Dec 31, 2021 | -22.95 Mn |
| Sep 30, 2021 | -20.75 Mn |
| Jun 30, 2021 | -18.79 Mn |
| Mar 31, 2021 | -9.95 Mn |
| Dec 31, 2020 | -11.73 Mn |
| Sep 30, 2020 | -10.79 Mn |
| Jun 30, 2020 | -8.07 Mn |
| Mar 31, 2020 | -10.51 Mn |
| Dec 31, 2019 | -7.90 Mn |
| Sep 30, 2019 | -6.40 Mn |
| Jun 30, 2019 | -7.67 Mn |
| Mar 31, 2019 | -7.85 Mn |
| Dec 31, 2018 | -6.41 Mn |
| Sep 30, 2018 | -4.93 Mn |
| Jun 30, 2018 | -3.31 Mn |
| Mar 31, 2018 | -3.85 Mn |
| Dec 31, 2017 | -5.92 Mn |
| Sep 30, 2017 | -5.09 Mn |